Related Experiment Video
Updated: Mar 5, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Relationship between Hepatitis C Virus Infection and Iron Overload
1Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Chronic hepatitis C (CHC) causes iron overload by decreasing hepcidin levels. Iron influences the hepatitis C virus (HCV) life cycle, particularly its translation.
Area of Science:
- Hepatology
- Virology
- Iron Metabolism
Background:
- Chronic hepatitis C (CHC) is frequently associated with iron overload.
- The interplay between iron metabolism and hepatitis C virus (HCV) infection is complex and not fully understood.
Purpose of the Study:
- To review the interactions between HCV infection and iron overload.
- To elucidate the mechanisms of iron overload in CHC.
- To understand iron's role in the HCV life cycle.
Main Methods:
- Literature review of PubMed articles up to January 28, 2017.
- Keywords included: "hepatitis C virus", "iron overload", "iron metabolism", "hepcidin", "translation", and "replication".
Main Results:
- HCV infection leads to iron overload through decreased hepcidin levels via specific signaling pathways (STAT3, MAPK, BMP/SMAD).
- Iron's effect on HCV replication is debated, with conflicting findings in studies.
- Most evidence suggests iron positively impacts HCV translation by upregulating factors like eIF3 and La protein.
Conclusions:
- CHC contributes to iron overload, which in turn influences the HCV life cycle.
- Further research is needed to fully clarify the intricate mechanisms governing the iron-HCV interaction.
More Related Videos
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Hepatic Drug Excretion: Influencing Factors